Shares of Eupraxia Pharmaceuticals Inc. (OTCMKTS:EPRXF – Get Free Report) were up 1.7% during mid-day trading on Friday . The stock traded as high as C$3.09 and last traded at C$3.05. Approximately 1,431 shares were traded during mid-day trading, a decline of 81% from the average daily volume of 7,410 shares. The stock had previously closed at C$3.00.
Eupraxia Pharmaceuticals Trading Up 1.7 %
The company has a 50 day simple moving average of C$3.19 and a 200 day simple moving average of C$2.80.
About Eupraxia Pharmaceuticals
Eupraxia Pharmaceuticals Inc, a clinical stage biotechnology company, engages in the discovery, development, and marketing of technologies in the biotechnology sector. The company's lead product candidate is EP-104IAR, which is in a Phase II clinical trial for the treatment of unmet medical needs and for pain relief for knee osteoarthritis and eosinophilic esophagitis, as well as under development for treating canine osteoarthritis.
Recommended Stories
- Five stocks we like better than Eupraxia Pharmaceuticals
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Driving Forward: Lucid’s Growing Sales and Gravity SUV’s Impact
- How to Calculate Return on Investment (ROI)
- Why Amazon’s Next Earnings Could Trigger a Stock Breakout
- Options Trading – Understanding Strike Price
- With This Kind of Data, The Fed Isn’t Cutting Rates This Year
Receive News & Ratings for Eupraxia Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eupraxia Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
